| Interventions | Ideal Intervention Index | Justified Non-Use Index | ||
| n* | (95% CI) | n† | (95% CI) | |
| Heart failure | 64 | 0.63 (0.51 to 0.75) | 41 | 0.41 (0.26 to 0.56) |
| ACEI or ARB | 21 | 0.86 (0.71 to 1.00) | 8 | 0.63 (0.27 to 0.99) |
| Bisoprolol, carvedilol, metoprolol | 21 | 0.57 (0.35 to 0.79) | 14 | 0.36 (0.10 to 0.62) |
| Spironolactone | 7 | 0.43 (0.03 to 0.83) | 8 | 0.50 (0.06 to 0.94) |
| Salt restriction | 15 | 0.47 (0.20 to 0.74) | 11 | 0.27 (0.00 to 0.55) |
| Coronary artery disease | 162 | 0.55 (0.47 to 0.63) | 79 | 0.55 (0.40 to 0.70) |
| Aspirin | 40 | 0.93 (0.85 to 1.00) | 19 | 0.84 (0.67 to 1.00) |
| Ramipril | 34 | 0.68 (0.52 to 0.84) | 27 | 0.59 (0.40 to 0.78) |
| Beta blockers | 40 | 0.83 (0.71 to 0.95) | 17 | 0.59 (0.35 to 0.83) |
| Statin | 48 | 0.71 (0.58 to 0.84) | 16 | 0.13 (0.00 to 0.30) |
| Ischaemic stroke | 30 | 1.00 (1.00 to 1.00) | 13 | 1.00 (1.00 to 1.00) |
| Aspirin | 30 | 1.00 (1.00 to 1.00) | 13 | 1.00 (1.00 to 1.00) |
| Atrial fibrillation | 28 | 0.79 (0.64 to 0.94) | 11 | 0.45 (0.14 to 0.76) |
| Warfarin | 28 | 0.79 (0.64 to 0.94) | 11 | 0.45 (0.14 to 0.76) |
| Type II diabetes | 84 | 0.72 (0.61 to 0.83) | 46 | 0.50 (0.35 to 0.65) |
| Aspirin | 29 | 0.72 (0.55 to 0.89) | 17 | 0.53 (0.29 to 0.77) |
| Statin | 33 | 0.64 (0.47 to 0.81) | 17 | 0.29 (0.07 to 0.51) |
| Ramipril | 20 | 0.85 (0.69 to 1.00) | 11 | 0.73 (0.51 to 0.95) |
| ACEI or ARB‡ | 1 | – (–) | 0 | – (–) |
| ARB‡ | 0 | – (–) | 1 | – (–) |
| Osteoporosis | 71 | 0.68 (0.57 to 0.79) | 30 | 0.23 (0.08 to 0.38) |
| Bisphosphonate+calcium+ vitamin D | 71 | 0.68 (0.57 to 0.79) | 30 | 0.23 (0.08 to 0.38) |
| History of fracture | 63 | 0.73 (0.62 to 0.84) | 23 | 0.26 (0.08 to 0.44) |
| Chronic corticosteroids | 8 | 0.38 (0.02 to 0.74) | 5 | 0.00 (0.00 to 0.00) |
| Smoker | 10 | 0.30 (0.00 to 0.60) | 7 | 0.00 (0.00 to 0.00) |
| Smoking cessation counselling or therapy | 10 | 0.30 (0.00 to 0.60) | 7 | 0.00 (0.00 to 0.00) |
*Number of ideal intervention opportunities.
†Number of total interventions not implemented.
‡Indices not calculated due to small number of patients enrolled with an indication for the intervention.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.